Skip to search formSkip to main contentSkip to account menu

carcinoma poorly differentiated

Known as: poorly differentiated carcinoma 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Thyroid cancer is the most common endocrine malignancy and its incidence goes on increasing worldwide. The majority of thyroid… 
Review
2012
Review
2012
We propose a new classification of thyroid follicular cell tumors which is correlated with patient's prognosis. It is unique as… 
2011
2011
BackgroundACC can occasionally undergo dedifferentiation also referred to as high-grade transformation (ACC-HGT). However, ACC… 
Highly Cited
1997
Highly Cited
1997
PURPOSE The objectives of this study were to assess clinical outcomes and prognostic factors in unselected, consecutive patients… 
Highly Cited
1997
Highly Cited
1997
PURPOSE To evaluate the efficacy and toxicity of a novel chemotherapy combination that includes paclitaxel, carboplatin, and… 
Highly Cited
1996
Highly Cited
1996
Highly Cited
1994
Highly Cited
1994
The expression of bcl-2 and p53 was investigated by immunocytochemistry in combination with that of conventional structural and… 
Highly Cited
1992
Highly Cited
1992
PURPOSE We previously reported excellent responses to cisplatin-based chemotherapy in a minority of patients with poorly… 
Review
1987
Review
1987
We have previously reported complete responses and long-term survival in patients with metastatic poorly differentiated carcinoma…